Hepatitis B Profile Test Price & Details at Chughtai Lab

Hepatitis B Profile at Chughtai Lab

The Hepatitis B Profile at Chughtai Lab is a comprehensive panel of serological blood tests designed to detect, diagnose, and monitor infections caused by the Hepatitis B Virus (HBV). Hepatitis B is a potentially life-threatening liver infection that can lead to chronic liver disease, cirrhosis, liver failure, and hepatocellular carcinoma. This profile evaluates a combination of viral antigens and host antibodies to provide a detailed picture of a patient’s infection status, immunity, and viral replication activity. By analyzing these specific biomarkers, clinicians can differentiate between acute and chronic infections, determine if a patient has acquired immunity through vaccination or past recovery, and monitor the effectiveness of antiviral therapies. Chughtai Lab, Pakistan’s premier diagnostic network, utilizes state-of-the-art automated chemiluminescent immunoassay (CLIA) technology to ensure the highest level of clinical sensitivity and specificity for every marker in this profile.

The clinical importance of the Hepatitis B Profile cannot be overstated. Because HBV infection can remain asymptomatic for decades while silently damaging the liver, early and accurate diagnosis is critical. The profile typically includes key markers such as Hepatitis B Surface Antigen (HBsAg), Hepatitis B Surface Antibody (anti-HBs), Total Hepatitis B Core Antibody (anti-HBc), IgM Antibody to Hepatitis B Core Antigen (IgM anti-HBc), Hepatitis B Envelope Antigen (HBeAg), and Hepatitis B Envelope Antibody (anti-HBe). Each marker represents a different phase of the viral life cycle and the body’s immunological response. Understanding these complex interactions allows gastroenterologists, hepatologists, and infectious disease specialists to make informed clinical decisions, prevent transmission, and implement timely therapeutic interventions to protect liver function.

Clinical Procedure: What to Expect

Patient Preparation

Preparing for a Hepatitis B Profile at Chughtai Lab is straightforward, as the test does not require complex interventions. To ensure optimal sample quality and accurate results, patients should adhere to the following guidelines:

• Fasting Requirements: Strict fasting is generally not required for a Hepatitis B Profile. Patients can eat and drink normally before the test. However, if other tests such as a fasting lipid profile or blood glucose are ordered concurrently, fasting guidelines for those specific tests must be followed.
• Medication Disclosure: Inform your healthcare provider and the laboratory staff about all medications, vitamins, and supplements you are currently taking. Certain immunosuppressive drugs or high-dose biotin supplements can potentially interfere with immunoassay testing methods.
• Hydration: Drink plenty of water prior to the blood draw. Being well-hydrated makes the veins more accessible, facilitating a smoother and quicker venipuncture process.
• Clothing: Wear a comfortable, loose-fitting shirt or a garment with sleeves that can be easily rolled up above the elbow to allow clear access to the venipuncture site.
• Anxiety Management: If you have a history of dizziness or fainting during blood draws, inform the phlebotomist beforehand so they can take appropriate precautions, such as performing the procedure while you are lying down.

During the Procedure

The Hepatitis B Profile is performed on a standard venous blood sample. The procedure is conducted by a highly trained and certified phlebotomist at Chughtai Lab, adhering to strict international safety and hygiene protocols:

• Patient Identification: The phlebotomist will first verify your identity using at least two identifiers (such as your name and lab registration number) to ensure absolute accuracy in sample labeling.
• Site Selection and Cleansing: The phlebotomist will examine your arm to locate a suitable vein, typically in the antecubital fossa (the crook of the elbow). Once selected, the area is thoroughly cleansed with an antiseptic swab (usually 70% isopropyl alcohol) and allowed to air dry.
• Tourniquet Application: A sterile elastic tourniquet is tied around your upper arm to restrict blood flow temporarily, causing the veins to swell and become more visible and accessible.
• Venipuncture: A sterile, single-use needle is gently inserted into the selected vein. You may feel a brief, mild pinch or stinging sensation as the needle enters the skin.
• Sample Collection: Blood is drawn into a specific vacuum tube (usually a gold-top serum separator tube or a red-top tube). The tourniquet is released once blood flow is established to minimize discomfort.
• Needle Removal and Hemostasis: The needle is carefully withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to stop any bleeding. A small adhesive bandage is then applied.
• Duration and Safety: The entire blood collection process takes less than five minutes. All equipment used is sterile, disposable, and discarded immediately after use in accordance with biohazard safety standards, eliminating any risk of cross-contamination.

When is a Hepatitis B Profile Performed?

Screening High-Risk Populations

Physicians frequently request a Hepatitis B Profile to screen individuals who have a higher risk of exposure to the virus. This includes healthcare workers exposed to blood and body fluids, individuals with multiple sexual partners, intravenous drug users, household contacts of HBV-infected individuals, and travelers to regions with high HBV prevalence. Screening helps detect asymptomatic infections early, allowing for timely intervention and preventing the accidental spread of the virus to others.

Evaluating Symptoms of Active Liver Disease

When a patient presents with clinical symptoms suggestive of acute or chronic hepatitis, a physician will order this profile to identify the underlying cause. Symptoms such as jaundice (yellowing of the skin and eyes), dark urine, pale stools, extreme fatigue, unexplained nausea, vomiting, and abdominal pain in the upper right quadrant point toward liver inflammation. The Hepatitis B Profile helps determine if HBV is the causative agent behind these symptoms.

Monitoring Chronic Hepatitis B Infection

For patients already diagnosed with chronic Hepatitis B, the profile is performed periodically to monitor the status of the infection. It helps assess whether the virus is actively replicating, which is indicated by the presence of HBeAg, or if the infection has transitioned into an inactive carrier state. This ongoing monitoring is crucial for determining when to initiate antiviral therapy and for evaluating how well the patient is responding to treatment.

Assessing Immunity Status Post-Vaccination

The Hepatitis B Profile is used to confirm whether an individual has developed adequate protective immunity following the completion of the Hepatitis B vaccine series. This is particularly important for healthcare professionals, students entering medical fields, and infants born to HBV-positive mothers. A positive result for Hepatitis B Surface Antibody (anti-HBs) with a titer greater than 10 mIU/mL indicates successful immunization and protection against future infection.

Pre-treatment and Prenatal Screening

Before initiating medical treatments that suppress the immune system, such as chemotherapy, biological therapies, or organ transplantation, physicians perform a Hepatitis B Profile. Immunosuppression can cause a latent or inactive HBV infection to reactivate violently, leading to acute liver failure. Additionally, prenatal screening is routinely performed on all pregnant women during the first trimester to identify HBV-positive mothers, enabling immediate post-delivery prophylaxis for the newborn to prevent vertical transmission.

What Does a Hepatitis B Profile Detect?

The Hepatitis B Profile detects a complex array of antigens and antibodies, each serving as a specific diagnostic marker. By analyzing the combination of these markers, the profile can detect and differentiate between the following clinical scenarios:

• Acute Hepatitis B Infection (Early Phase): Detected by the presence of Hepatitis B Surface Antigen (HBsAg) before symptoms appear, indicating an active, ongoing infection.
• Acute Hepatitis B Infection (Active Phase): Characterized by positive HBsAg, positive IgM anti-HBc (indicating recent infection), and positive HBeAg (indicating high viral replication and infectivity).
• Chronic Hepatitis B Infection (Active Replication): Indicated by the persistence of HBsAg for more than six months, along with positive HBeAg and total anti-HBc, showing that the virus is actively multiplying and causing ongoing liver inflammation.
• Chronic Hepatitis B Infection (Inactive Carrier): Identified when HBsAg is present for over six months, but HBeAg is negative and anti-HBe is positive, indicating low viral replication and reduced infectivity.
• Resolved Past Infection: Indicated by the absence of HBsAg, combined with positive anti-HBs and positive total anti-HBc. This pattern shows the patient had Hepatitis B in the past but has cleared the virus naturally and is now immune.
• Vaccine-Induced Immunity: Characterized solely by the presence of anti-HBs, while all other markers (HBsAg, anti-HBc, HBeAg) remain negative. This confirms successful immunization.
• The “Window Period” of Acute Infection: A phase where HBsAg has cleared but anti-HBs has not yet reached detectable levels. During this time, IgM anti-HBc may be the only detectable marker of an active acute infection.
• Occult Hepatitis B Infection: A rare state where HBsAg is undetectable in the blood, but HBV DNA is present in the liver or serum, sometimes suggested by an isolated positive total anti-HBc result.
• HBeAg-Negative Chronic Hepatitis B: A variant of chronic infection where the virus has mutated and cannot produce HBeAg, yet continues to replicate actively, marked by positive HBsAg, negative HBeAg, positive anti-HBe, and elevated liver enzymes.
• Early Seroconversion: The transition phase where HBeAg is disappearing and anti-HBe is appearing, signaling a favorable shift toward lower viral activity.
• High Risk of Vertical Transmission: Indicated by high levels of HBsAg and HBeAg in a pregnant woman, signaling a high viral load that poses a significant risk of transmitting the virus to the fetus during delivery.
• Susceptibility to Infection: When all markers in the profile (HBsAg, anti-HBs, anti-HBc) are completely negative, indicating the patient has never been exposed to the virus and has not been vaccinated, leaving them fully susceptible.
• Reactivation of Latent Infection: Detected in immunosuppressed patients when previously negative HBsAg or HBeAg markers become positive again, accompanied by a rapid rise in viral replication.
• Efficacy of Antiviral Therapy: Monitored through the loss of HBeAg and the development of anti-HBe (seroconversion), which indicates successful suppression of the virus by medication.
• Immune Tolerant Phase: Often seen in young individuals infected at birth, characterized by positive HBsAg, positive HBeAg, very high viral loads, but normal liver enzymes and minimal liver inflammation.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing rapid, accurate, and easily accessible diagnostic reports. For a standard Hepatitis B Profile, the turnaround time is typically within 12 to 24 hours from the time of sample collection. Because Chughtai Lab utilizes fully automated, high-throughput immunoassay analyzers, processing times are minimized without compromising clinical accuracy. Once the results are verified by a consultant pathologist, patients receive an automated SMS notification containing a direct link to download their report. Reports can also be accessed online through the official Chughtai Lab website portal or via the user-friendly Chughtai Lab mobile application. Physical copies of the reports can be collected from any Chughtai Lab collection center nationwide. This seamless digital integration ensures that patients and their treating physicians can access critical diagnostic data promptly, facilitating timely clinical decisions.

Hepatitis B Profile Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hepatitis B Surface Antigen (HBsAg)	Negative (Non-reactive)	Positive (Reactive): Indicates active acute or chronic Hepatitis B infection.
Hepatitis B Surface Antibody (anti-HBs)	Positive (>10 mIU/mL) if vaccinated	Negative (<10 mIU/mL): Indicates lack of immunity or non-response to vaccine.
Total Hepatitis B Core Antibody (anti-HBc)	Negative (Non-reactive)	Positive (Reactive): Indicates past resolved or current ongoing HBV infection.
IgM Core Antibody (IgM anti-HBc)	Negative (Non-reactive)	Positive (Reactive): Indicates recent acute Hepatitis B infection (within 6 months).
Hepatitis B Envelope Antigen (HBeAg)	Negative (Non-reactive)	Positive (Reactive): Indicates high viral replication, high infectivity, and active disease.
Hepatitis B Envelope Antibody (anti-HBe)	Negative (Non-reactive)	Positive (Reactive): Indicates low viral replication, transition to inactive carrier state.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Hepatitis B Profile?

• Experienced Healthcare Professionals: All tests are conducted by certified phlebotomists and reviewed by highly qualified consultant pathologists.
• Patient-Focused Care: Chughtai Lab prioritizes patient comfort, safety, and confidentiality throughout the diagnostic process.
• Quality Diagnostic Services: Operating under strict international quality control standards to deliver highly accurate and reproducible results.
• Professional Reporting: Clear, structured, and easy-to-read reports that facilitate quick clinical interpretation by physicians.
• Modern Diagnostic Approach: Equipped with advanced, fully automated chemiluminescent immunoassay (CLIA) systems for precise testing.
• Comfortable Environment: Clean, hygienic, and welcoming collection centers designed to provide a stress-free experience for patients.
• Convenient Location: An extensive network of collection points across Pakistan, making quality diagnostics accessible to everyone.
• Commitment to Accurate Diagnosis: Dedicated to maintaining the highest standards of laboratory medicine to support effective patient care.